Tuesday, 02 January 2024 12:17 GMT
عربي


               US          Europe          Arab          Asia          Africa    
|      Politics          Economy     Oil&Energy         
                 Entertainment          Sport
Satellos Bioscience Inc.

Satellos Bioscience Inc.


2026-05-15 12:32:26
(MENAFN- Baystreet) 11:37 AM EST - Satellos Bioscience Inc.: Announced financial results and corporate highlights for the first quarter ended March 31, 2026. Satellos Bioscience Inc. Satellos reported a net loss of $9.8 million ($0.53 loss per share), compared to a net loss of $6.1 million ($0.44 loss per share) for the quarter ended March 31, 2025. shares T are trading down $0.19 at $9.78.

MENAFN15052026000212011056ID1111122199



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Tags

Label

Comments

No comment

Category

Date
Search